Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Dilip Shanghvi

    Tag: dilip shanghvi

    You Searched For "Dilip Shanghvi"
    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Sun Pharma reports Rs 6923.40 crore total expenses in Q3

    Farhat Nasim7 Feb 2020 4:43 PM IST
    New Delhi: Drug major Sun Pharmaceutical Industries on Thursday reported a 26.43 per cent decline in its consolidated net profit to Rs 913.52 crore...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Medical Dialogues Bureau4 Sept 2019 5:18 PM IST
    New Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Medical Dialogues Bureau16 Aug 2019 9:30 AM IST
    Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
    Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

    Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

    Farhat Nasim3 Aug 2019 3:26 PM IST
    Mumbai: In a move that will axe job of around 85 employees (as pegged my market sources), Dilip Shanghvi led Sun Pharmaceuticals Ltd. (Sun Pharma) has...
    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Medical Dialogues Bureau1 Aug 2019 10:00 AM IST
    The company is targeting key ailments like psoriasis to gradually ramp up its global speciality business, Dilip Shanghvi said adding that Sun Pharma...
    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Sun Pharma enters licensing agreement with CMS for arthritis drug Tildrakizumab

    Medical Dialogues Bureau28 Jun 2019 12:30 PM IST
    The initial tenure of the agreement between Sun Pharma and CMS shall be 15 years from the first commercial sale of Tildrakizumab in Greater China and...
    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Ressurecting Sun Pharma: Shanghvi committed to pharma business; surrenders NBFC licence

    Meghna A Singhania29 May 2019 2:37 PM IST
    New Delhi: The billionaire entrepreneur, Dilip Shanghvi, founder of the 1983 established drug giant Sun Pharmaceuticals (Sun Pharma) is striving to...
    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Sun Pharma Q4 profit falls by half to Rs 636 crore due to change in distribution strategy

    Garima29 May 2019 9:45 AM IST
    Sun Pharma said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of...
    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Dilip Shanghvi plans comeback; Sun Pharma to develop its own medicines: Report

    Meghna A Singhania26 May 2019 6:13 PM IST
    Shanghvi estimates that Sun Pharma has invested about $1 billion in its patented-drug programme so far. He says growth in the Indian generics...
    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Sun Pharma submits proposal to CDSCO for manufacturing, marketing FDC to treat URTI; Details

    Meghna A Singhania25 May 2019 11:15 AM IST
    New Delhi: Dilip Shanghvi led Sun Pharma recently submitted a proposal to seek permission from the national regulatory authority, Central Drugs...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 9:15 AM IST
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok